UnknownPhase 1/2

Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH

64 participantsStarted 2015-11

Plain-language summary

The aim of this study is to compare the effect of low dose of Tranexamic acid (1gm) and Ethamsylate (1gm) after prophylactic oxytocin administration versus placebo with prophylactic oxytocin given in the 2 minutes after child delivery in patient undergoing LSCS at high risk for post partum hemorrhage

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Women undergoing elective caesarean section
✓. Patient having one or more risk factor for PPH
✓. Age ≥18 years
✓. Gestational Age ≥ 35 Weeks
✓. Informed Oral Consent From The Patient

Exclusion criteria

✕. History of venous thrombosis (DVT and/or Pulmonary embolism) OR arterial thrombosis (angina pectoris , myocardial infarction, stroke)
✕. History of epilepsy or seizure
✕. Any Known Cardiovascular , renal or liver Disease
✕. Autoimmune Diseases
✕. Sickle Cell Disease
✕. Severe hemorrhagic Disease
✕. Placenta Previa.
✕. Morbidly adherent Placenta

What they're measuring

PPH defined as blood loss ≥500 cc

Timeframe: the first 24hours

Trial details

NCT IDNCT02604719

SponsorAhmed Alanwar

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-05

Contact for this trial

ahmed Dr alanwar, MD

+201111486669 eladwar@hotmail.com

View on ClinicalTrials.gov More Postpartum Hemorrhage trials